Talis Biomedical Corporat... (TLIS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.57
0.00 (0.00%)
At close: Jan 24, 2025, 3:56 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 76.73M | 130.19M | 232.54M | 138.48M | 21.60M | 6.89M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 1.78M | 767.00K | n/a | n/a | n/a |
Other Long-Term Assets | 1.54M | 1.78M | 5.51M | n/a | 91.00K | 231.00K |
Receivables | 50.00K | 308.00K | 183.00K | 471.00K | 1.81M | 2.00M |
Inventory | n/a | n/a | n/a | 46.66M | n/a | n/a |
Other Current Assets | 901.00K | 2.78M | 3.39M | 49.77M | 697.00K | 444.00K |
Total Current Assets | 77.68M | 133.28M | 236.12M | 188.72M | 24.11M | 9.34M |
Property-Plant & Equipment | 15.45M | 34.23M | 23.43M | 9.68M | 1.53M | 1.81M |
Goodwill & Intangibles | n/a | -9.24M | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 16.99M | 36.01M | 29.71M | 9.68M | 1.63M | 2.04M |
Total Assets | 94.67M | 169.29M | 265.83M | 198.41M | 25.73M | 11.38M |
Account Payables | 1.34M | 3.77M | 5.12M | 4.91M | 1.57M | 1.51M |
Deferred Revenue | n/a | n/a | 11.67M | 9.71M | 235.00K | 212.00K |
Short-Term Debt | 2.88M | 7.41M | 2.46M | 1.39M | n/a | n/a |
Other Current Liabilities | 4.55M | 1.50M | 11.52M | 9.73M | 2.47M | 1.65M |
Total Current Liabilities | 8.77M | 12.67M | 19.11M | 16.03M | 4.04M | 3.37M |
Long-Term Debt | 16.79M | 29.88M | 12.74M | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 290.95M | 42.76M | 59.70M |
Total Long-Term Liabilities | 16.79M | 29.88M | 12.74M | 290.95M | 42.84M | 60.01M |
Total Liabilities | 25.56M | 42.55M | 31.85M | 306.98M | 46.87M | 63.38M |
Total Debt | 19.67M | 33.58M | 13.98M | 693.00K | n/a | n/a |
Common Stock | n/a | 3.00K | 3.00K | n/a | n/a | n/a |
Retained Earnings | -539.96M | -477.95M | -364.94M | -172.91M | -81.78M | -54.30M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -1.51M |
Shareholders Equity | 69.12M | 126.74M | 233.98M | -108.57M | -21.14M | -52.00M |
Total Investments | 1.54M | 1.78M | 767.00K | n/a | n/a | n/a |